drugset / Trial / NCT00177021
Aldara for the Treatment of Extensive Alopecia Areata
Phase 4
Completed
20 enrolled
Hordinsky, Maria K., MD
3M · collabNational Alopecia Areata Foundation · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
We propose to examine the efficacy and tolerability of Aldara Cream 5% for the treatment of extensive alopecia areata. Aldara is a immune-response modifier. The drug induces the production of cytokines which are small, hormone-like proteins involved in cellular communication during immune responses. We hypothesize that this drug will effect the inflammatory cells present around hair follicles in patients with alopecia areata.
Timeline
- Start
- 2000-10
- Primary completion
- —
- Completion
- 2002-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imiquimod | Other / unclassified | 5 % | Topical |